Liabilities / Assets
26th percentile
Higher debt load relative to assets than 26% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.05x
Liabilities / Revenue
22nd percentile
Higher debt load relative to revenue than 22% of similar nonprofits.
Net Margin
68th percentile
Higher net margin than 68% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
39th percentile
Faster asset growth than 39% of similar nonprofits.
Revenue Growth
61st percentile
Faster revenue growth than 61% of similar nonprofits.
Balance Sheet
Assets
Up$13,751,271
Up $229,205 (+1.7%) from 2016
Net Assets
Up$13,131,357
Up $1,265,506 (+11%) from 2016
Liabilities
Down$619,914
Down $1,036,301 (-63%) from 2016
Revenue And Expenses
Revenue
Up$8,648,060
Up $705,308 (+8.9%) from 2016
Expenses
Up$7,768,786
Up $617,118 (+8.6%) from 2016
Net Income
Up$879,274
Up $88,190 (+11%) from 2016
Historical Trend
Filing Detail Status
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2017 to Dec 31, 2017
Mission and Program Overview
Mission
To conduct translational "bench to bedside" research. To provide consultation, histology, and diagnostic services to promote discoveries towards advancing treatments for cardiovascular diseases.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $13,751,271
- Liabilities
- $619,914
- Net assets
- $13,131,357
- Revenue
- $8,648,060
- Expenses
- $7,768,786
- Net income
- $879,274